GELESIS HOLDINGS, INC.

Gelesis Holdings, Inc., trading under ticker CPSR, was a blank-check company sponsored by Capstar SPAC Sponsor LLC that completed its initial public offering in January 2021, targeting the healthcare and medical technology sector. The 10-Q filed on November 16, 2021, with accession number 0001104659-21-139442, was submitted during the period preceding the company's anticipated de-SPAC combination with Gelesis, Inc., a Boston-based biotech focused on hydrogel-based weight management therapeutics. At the time of filing, the proposed business combination had been announced and was pending shareholder and regulatory approval, with the transaction ultimately closing in early 2022. Visit SpacDesk and sign up for full filings, status timelines, and deal analytics on CPSR and hundreds of other SPAC transactions.